Register entryShortage reported
Ferring Pharmaceuticals Inc.
- Registered sites
- 9
- Drug products
- 17
- Live patents
- 34
- Countries
- 7
- Base
- Germany
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
9| Site | Location | Operations | FEI |
|---|---|---|---|
| Instituto Massone S.A. | Buenos AiresArgentina | Active ingredient (API) manufacture | 3002807270 |
| Ferring International Center SA | St-PrexSwitzerland | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3005724652 |
| Huiling Pharmaceutical (China) Co., Ltd. | ZhongshanChina | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3009226362 |
| Ferring GmbH | KielGermany | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002806979 |
| Minerva Analytix GmbH | RangsdorfGermany | Analytical testing | 3004153526 |
| Ferring Controlled Therapeutics Ltd. | GlasgowUnited Kingdom | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002806756 |
| Bio-Technology General (Israel) Ltd. | Kiryat MalachiIsrael | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3000164186 |
| Ferring Production Inc. | Parsippany, NJUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3011163401 |
| Ferring Microbiome Inc. | Saint Paul, MNUnited States | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3012047188 |
Alert
Products in shortage
3| Drug | Presentation | Availability |
|---|---|---|
| Desmopressin Acetate Spray | Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0) | Unavailable |
| Desmopressin Acetate Spray | Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05) | Unavailable |
| Desmopressin Acetate Spray | Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00) | Unavailable |
Exclusivity
Patents
34Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| CLENPIQ | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | Jun 2034 |
| CLENPIQ | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | Jun 2034 |
| CLENPIQ | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | Jan 2038 |
| FIRMAGON | DEGARELIX ACETATE | Feb 2029 |
| FIRMAGON | DEGARELIX ACETATE | Feb 2029 |
| FIRMAGON | DEGARELIX ACETATE | Apr 2032 |
| MILPROSA | PROGESTERONE | Feb 2029 |
| MILPROSA | PROGESTERONE | Jan 2030 |
| NOCDURNA | DESMOPRESSIN ACETATE | May 2029 |
| NOCDURNA | DESMOPRESSIN ACETATE | Apr 2030 |
| PREPOPIK | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | Oct 2028 |
Catalogue
Marketed products
17Showing 17 of 17.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ADSTILADRIN | nadofaragene firadenovec-vncg | SUSPENSION | BLA |
| CERVIDIL | DINOPROSTONE | INSERT | NDA |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID | LIQUID | NDA |
| DDAVP | Desmopressin Acetate | INJECTION | NDA |
| DDAVP | Desmopressin Acetate | INJECTION | NDA |
| DDAVP | Desmopressin Acetate | TABLET | NDA |
| DDAVP | Desmopressin Acetate | TABLET | NDA |
| ENDOMETRIN | Progesterone | INSERT | NDA |
| FIRMAGON | Degarelix | KIT | NDA |
| FIRMAGON | Degarelix | KIT | NDA |
| Fyremadel | ganirelix acetate | INJECTION, SOLUTION | ANDA |
| Menopur | menotropins | KIT | BLA |
| Novarel | gonadotrophin, chorionic | KIT | BLA |
| Rebyota | Donor Human Stool | SUSPENSION | BLA |
| Stimate | desmopressin acetate | SPRAY | NDA |
| ZOMACTON | somatropin | KIT | BLA |
| ZOMACTON | somatropin | KIT | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.